Akanda Corp. balance sheet
At the end of fiscal 2025, Akanda Corp. had total assets of $6.2m, total liabilities of $18.2m and shareholders' equity of −$12.0m. It held $504,136 in cash against $1.0m of debt: net debt of $502,784.
Balance sheet
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 0 | 3 | 0 | 0 | 4 | 1 |
| Receivables | — | 0 | 1 | 0 | 0 | 1 |
| Inventory | 0 | — | 1 | 1 | — | — |
| Total current assets | 0 | 4 | 4 | 2 | 5 | 4 |
| Goodwill | — | — | — | — | — | 40 |
| Total assets | 4 | 8 | 39 | 9 | 8 | 6 |
| Total current liabilities | 3 | 8 | 9 | 10 | 4 | 6 |
| Short-term debt | — | — | 1 | 1 | 0 | 1 |
| Long-term debt | — | — | 3 | 2 | — | — |
| Total debt | 0 | 7 | 4 | 4 | 0 | 1 |
| Total liabilities | 9 | 10 | 12 | 13 | 4 | 18 |
| Shareholders' equity | −5 | −2 | 27 | −4 | 4 | −12 |
| Net debt (negative = net cash) | −0 | 3 | 3 | 4 | −3 | 1 |
Compare with peers
- Scienture Holdings, Inc. balance sheet
- 60 Degrees Pharmaceuticals, Inc. balance sheet
- China SXT Pharmaceuticals, Inc. balance sheet
- Lipocine Inc. balance sheet
- Nutriband Inc. balance sheet
Head to head: AKAN vs SCNXAKAN vs SXTPAKAN vs SXTC
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies